Aspirin Cuts Colon Cancer Risk
Previously, low-dose aspirin is also recommended for patients who have a high risk of heart attack and stroke. In the prevention of colon cancer, aspirin in high doses are effective but have side effects of bleeding.
Therefore, experts tried to examine whether if the dose is lowered, the protection effect remains the same. In the study researchers followed up four research conducted in England and Sweden between the years 1980-1990 on the effects of aspirin in cardiovascular patients.
In general, from the research for six years, participants were asked to take aspirin in doses of 1200 mg or placebo pills. More than 14,000 patients who’s medical history were followed for 18 years, 391 suffered colorectal cancers.
For those who took aspirin, the risk of cancer was reduced by 24 percent and mortality risk can be reduced to 35 percent. The results of this research is consistent in the four studies. Unfortunately there are no data on side effects in long-term aspirin use because since the beginning, this study was designed to examine cardiovascular disease.
“The results of this study indicate the use of low-dose aspirin in a long term in combination with screening can reduce the incidence of cancer throughout the colon and rectum,” says Peter Rothwell, of Oxford University.
Colorectal cancer is one of the most common types of cancer which occur in men and women. The risk of this cancer seems more frequent in those with eating pattern high in fat and low in vegetables and fresh fruit. Colorectal cancer risk are also higher in smokers, alcoholics and those with less exercise.